Breast Cancer Metastasis and Drug Resistance Challenges and Progress /
Resistance to therapies, both targeted and systemic, and metastases to distant organs are the underlying causes of breast cancer-associated mortality. The second edition of Breast Cancer Metastasis and Drug Resistance brings together some of the leading experts to comprehensively understand breast c...
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Language: | English |
| Published: |
Cham :
Springer International Publishing : Imprint: Springer,
2019.
|
| Edition: | 2nd ed. 2019. |
| Series: | Advances in Experimental Medicine and Biology,
1152 |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/978-3-030-20301-6 |
Table of Contents:
- Chaper 1: Breast Cancer Statistics: Recent trends
- Chapter 2: Epidemiology of Breast Cancer in Women
- Chapter 3: Health and Racial Disparity in Breast Cancer
- Chapter 4: Breast Cancer: Current perspectives on the disease status
- Chapter 5: Role of Autophagy in Breast Cancer Development and Progression: Opposite Sides of the Same Coin
- Chapter 6: Breast Cancer Heterogeneity in Primary and Metastatic Disease
- Chapter 7: Bone Metastasis of Breast Cancer
- Chapter 8: Therapeutic Options for Metastatic Breast Cancer
- Chapter 9: Chemotherapy and inflammatory cytokine signalling in cancer cells and the tumour microenvironment
- Chapter 10: Current Updates on Trastuzumab Resistance in HER2 overexpressing Breast Cancers
- Chapter 11: Non-coding RNAs as mediators of tamoxifen resistance in breast cancers
- Chapter 12: TRAIL Mediated Signaling in Breast Cancer: Awakening Guardian Angel to Induce Apoptosis and Overcome Drug Resistance
- Chapter 13: Current state of platinum complexes for the treatment of advanced and drug-resistant breast cancers
- Chapter 14: Targeting of JAK-STAT Signaling in Breast Cancer: Therapeutic Strategies to Overcome Drug Resistance
- Chapter 15: Role of mTORC1 and mTORC2 in Breast Cancer: Therapeutic Targeting of mTOR and its Partners to Overcome Metastasis and Drug Resistance
- Chapter 16: Epigenetics of Breast Cancer: Clinical Status of Epi-Drugs and Phytochemicals
- Chapter 17: Targeting CSC in a most aggressive subtype of breast cancer TNBC
- Chapter 18: Cross-roads to drug resistance and metastasis in breast cancer: miRNAs regulatory function and biomarker capability
- Chapter 19: NEDD4 Family of E3 Ubiquitin Ligases in Breast Cancer: Spotlight on SMURFs, WWPs and NEDD4
- Chapter 20. Emerging Novel Therapeutics in Triple-Negative Breast Cancer
- Chapter 21.Breast Cancer: Proteolysis and Migration
- Chapter 22: Current and emerging 3D models to study breast cancer.